-
Novel Cancer Therapy Phase 3 Trial Expects To Be Completed Shortly
Tuesday, April 6, 2021 - 9:07am | 912The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. As science advances in terms of finding new treatments for unmet medical needs, certain approaches are not appropriate for specific types...
-
3 Penny Stocks To Buy According To Top Stock Market Analysts
Monday, March 1, 2021 - 5:11pm | 1532The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Penny Stocks To Buy With Price Targets Up To 168% According To Analysts Maxim Group & H.C. Wainwright. There is blood in the water...
-
Fortress Biotech CEO Explains The Company's Three-Step Business Model
Tuesday, February 23, 2021 - 10:08am | 728The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Companies within the fields of biotechnology and pharmaceuticals work to develop medicines for the treatment of various diseases and...
-
The Week Ahead In Biotech: Decision Day For Bausch Health, IPO Flow Resumes, Oncology Conference
Sunday, September 13, 2020 - 9:49am | 1518Biotech stocks continued to remain under pressure in the week ended Sept. 11, swayed by the volatility that was evident in the broader market. The week also witnessed a flurry of news flow on the coronavirus vaccine front. Even as nine vaccine makers released a pledge to put safety first,...